Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4413)
All Articles published online
|
Jan 21, 2008 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Saich R, Chapman R. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. World J Gastroenterol 2008; 14(3): 331-337 [PMID: 18200656 DOI: 10.3748/wjg.14.331] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i3/331.htm |
| Number | Citing Articles |
| 1 |
Daniel C Baumgart, James N Lowder, Stephan R Targan, William J Sandborn, Matthew B Frankel. Transient Cytokine-Induced Liver Injury Following Administration of the Humanized Anti-CD3 Antibody Visilizumab (HuM291) in Crohn's Disease. The American Journal of Gastroenterology 2009; 104(4): 868 doi: 10.1038/ajg.2008.138
|
| 2 |
|
| 3 |
Davide De Marco, Amine Benmassaoud. Practical approach to abnormal liver enzymes in patients with inflammatory bowel disease. Canadian IBD Today 2023; doi: 10.58931/cibdt.2023.1317
|
| 4 |
Nora Schweitzer, Michael P. Manns. Crohn's Disease and Ulcerative Colitis. 2012; : 565 doi: 10.1007/978-1-4614-0998-4_46
|
| 5 |
Christopher L. Bowlus. Cutting Edge Issues in Primary Sclerosing Cholangitis. Clinical Reviews in Allergy & Immunology 2011; 41(2): 139 doi: 10.1007/s12016-010-8221-3
|
| 6 |
Eun Yeong Kim, Hyo Jong Kim, Chang Kyun Lee, Choul Ki Park, Hee Jae Hyun, Yeon Ju Kim, Kyung Yup Kim. A Case of Cholangiocarcinoma and Colorectal Cancer Diagnosed Simultaneously in a Patient with Ulcerative Colitis and Concurrent Primary Sclerosing Cholangitis. Intestinal Research 2012; 10(4): 392 doi: 10.5217/ir.2012.10.4.392
|
| 7 |
V.J. Desmet, Juan Rosai. Rosai and Ackerman's Surgical Pathology. 2011; : 857 doi: 10.1016/B978-0-323-06969-4.00001-5
|
| 8 |
Sophie Restellini, Olivier Chazouillères, Jean‐Louis Frossard. Hepatic manifestations of inflammatory bowel diseases. Liver International 2017; 37(4): 475 doi: 10.1111/liv.13265
|
| 9 |
Carles Leal-Valdivieso, Juan E. Naves, Míriam Mañosa, Yamile Zabana, Eduard Cabré, Eugeni Domènech. Hipertensión portal en pacientes con enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 2010; 33(4): 297 doi: 10.1016/j.gastrohep.2009.12.003
|
| 10 |
Jonathan H. Aron, Christopher L. Bowlus. The immunobiology of primary sclerosing cholangitis. Seminars in Immunopathology 2009; 31(3): 383 doi: 10.1007/s00281-009-0154-7
|
| 11 |
Philippe J. Zamor. Diagnosis and Management of Autoimmune Hepatitis. 2020; : 137 doi: 10.1007/978-3-030-33628-8_10
|
| 12 |
Marilena Durazzo, Alberto Premoli, Elena Paschetta, Paola Belci, Maurizio Spandre, Simona Bo. Overlap Syndromes of Autoimmune Hepatitis: An Open Question. Digestive Diseases and Sciences 2013; 58(2): 344 doi: 10.1007/s10620-012-2378-y
|
| 13 |
Nathaniel S Rial, Kevin B Gilchrist, Jeff T Henderson, Achyut K Bhattacharyya, Thomas D Boyer, Abdul Nadir, John T Cunningham. Endoscopic ultrasound with biopsy of omental mass for cholangiocarcinoma diagnosis in cirrhosis. World Journal of Gastrointestinal Endoscopy 2011; 3(6): 124-128 doi: 10.4253/wjge.v3.i6.124
|
| 14 |
Chengdong Yu, Jiawei Xu, Siyi Xu, Lei Tang, Qinyuan Han, Xiaoqiang Zeng, Yanxiao Huang, Tenghua Yu, Zhengkui Sun. Exploring genetic associations of Crohn’s disease and ulcerative colitis with extraintestinal cancers in European and East Asian populations. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1339207
|
| 15 |
Matthew A Heckroth, Mohamed Eisa, Matthew Cave. Resolution of Autoimmune Hepatitis Following Total Colectomy in Severe Ulcerative Colitis: A Rare Presentation Associated With Leaky Gut. Cureus 2021; doi: 10.7759/cureus.19276
|
| 16 |
Jeana Hong, Mi Kyoung Song, Jae Sung Ko, Gyeong Hoon Kang, Woo Sun Kim, Jeong Kee Seo. Autoimmune hepatitis-primary sclerosing cholangitis overlap syndrome in a 10-year-old girl with ulcerative colitis. Korean Journal of Pediatrics 2009; 52(4): 504 doi: 10.3345/kjp.2009.52.4.504
|
| 17 |
J.-F. Cadranel. Elevación crónica de las transaminasas: hipertransaminasemia crónica. EMC - Tratado de Medicina 2011; 15(2): 1 doi: 10.1016/S1636-5410(11)71025-X
|
| 18 |
Felipe Ordonez, Florence Lacaille, Danielle Canioni, Cecile Talbotec, Jean-Christophe Fournet, Nadine Cerf-Bensussan, Olivier Goulet, Jacques Schmitz, Frank M. Ruemmele. Pediatric ulcerative colitis associated with autoimmune diseases: A distinct form of inflammatory bowel disease?. Inflammatory Bowel Diseases 2012; 18(10): 1809 doi: 10.1002/ibd.22864
|
| 19 |
Federica Fascì-Spurio, Polychronis Pavlidis, Ingvar Bjarnason. A new form of chronic inflammatory bowel disease associated with chronic liver disease. Scandinavian Journal of Gastroenterology 2016; 51(6): 644 doi: 10.3109/00365521.2015.1128141
|
| 20 |
Natalie A. Molodecky, Hashim Kareemi, Rohan Parab, Herman W. Barkema, Hude Quan, Robert P. Myers, Gilaad G. Kaplan. Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis. Hepatology 2011; 53(5): 1590 doi: 10.1002/hep.24247
|
| 21 |
|
| 22 |
Ersilia M. DeFilippis, Randy Longman, Michael Harbus, Kyle Dannenberg, Ellen J. Scherl. Crohn’s Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies. Current Gastroenterology Reports 2016; 18(3) doi: 10.1007/s11894-016-0487-z
|
| 23 |
Crystal Knight, Karen F Murray. Hepatobiliary associations with inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2009; 3(6): 681 doi: 10.1586/egh.09.53
|
| 24 |
R. Nolz, U. Asenbaum, M. Schoder, A. Wibmer, H. Einspieler, A.M. Prusa, M. Peck-Radosavljevic, A. Ba-Ssalamah. Diagnostic workup of primary sclerosing cholangitis: The benefit of adding gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography to conventional T2-weighted magnetic resonance cholangiography. Clinical Radiology 2014; 69(5): 499 doi: 10.1016/j.crad.2013.12.008
|
| 25 |
Atsushi Tanaka, Joachim C. Mertens. Ulcerative Colitis with and without Primary Sclerosing Cholangitis: Two Different Diseases?. Inflammatory Intestinal Diseases 2016; 1(1): 9 doi: 10.1159/000445259
|
| 26 |
Natalie A. Molodecky, Robert P. Myers, Herman W. Barkema, Hude Quan, Gilaad G. Kaplan. Validity of administrative data for the diagnosis of primary sclerosing cholangitis: a population-based study. Liver International 2011; 31(5): 712 doi: 10.1111/j.1478-3231.2011.02484.x
|
| 27 |
Michael P. Manns, Nora Schweitzer. Crohn's Disease and Ulcerative Colitis. 2017; : 521 doi: 10.1007/978-3-319-33703-6_51
|
| 28 |
Jeffrey S. Chang, Chia-Rung Tsai, Li-Tzong Chen, Fu-Sheng Wang. Medical Risk Factors Associated with Cholangiocarcinoma in Taiwan: A Population-Based Case-Control Study. PLoS ONE 2013; 8(7): e69981 doi: 10.1371/journal.pone.0069981
|
| 29 |
Besrat Berhane, Patrick F. van Rheenen, Henkjan J. Verkade. Gamma‐glutamyl transferase and disease course in pediatric‐onset primary sclerosing cholangitis: A single‐center cohort study. Health Science Reports 2023; 6(2) doi: 10.1002/hsr2.1086
|
| 30 |
A. Vidas Natasha. Advanced Nutrition and Dietetics in Gastroenterology. 2014; : 273 doi: 10.1002/9781118872796.ch4.2
|
| 31 |
Albert J. Czaja. Clinical Epidemiology of Chronic Liver Diseases. 2019; : 251 doi: 10.1007/978-3-319-94355-8_16
|
| 32 |
KASL clinical practice guidelines for management of autoimmune hepatitis 2022. Clinical and Molecular Hepatology 2023; 29(3): 542 doi: 10.3350/cmh.2023.0087
|
| 33 |
Nadan Rustemovic, Silvija Cukovic-Cavka, Milorad Opacic, Mladen Petrovecki, Irena Hrstic, Davor Radic, Rajko Ostojic, Roland Pulanic, Boris Vucelic. Endoscopic ultrasound elastography as a method for screening the patients with suspected primary sclerosing cholangitis. European Journal of Gastroenterology & Hepatology 2009; : 1 doi: 10.1097/MEG.0b013e32832d489f
|
| 34 |
Rui Gaspar, Catarina Castelo Branco, Guilherme Macedo. Liver manifestations and complications in inflammatory bowel disease: A review. World Journal of Hepatology 2021; 13(12): 1956-1967 doi: 10.4254/wjh.v13.i12.1956
|
| 35 |
Marc Girardin, Antoine Hadengue, Jean-Louis Frossard, the Swiss IBD Cohort Study Group. High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients. World Journal of Clinical Cases 2018; 6(4): 44-53 doi: 10.12998/wjcc.v6.i4.44
|
| 36 |
Wolfgang Stremmel, Simone Staffer, Ralf Weiskirchen. Phosphatidylcholine Passes by Paracellular Transport to the Apical Side of the Polarized Biliary Tumor Cell Line Mz-ChA-1. International Journal of Molecular Sciences 2019; 20(16): 4034 doi: 10.3390/ijms20164034
|
| 37 |
Ye H. Oo, Stefan G. Hubscher, David H. Adams. Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management. Hepatology International 2010; 4(2): 475 doi: 10.1007/s12072-010-9183-5
|
| 38 |
Olivier Chazouilleres, Ulrich Beuers, Annika Bergquist, Tom Hemming Karlsen, Cynthia Levy, Marianne Samyn, Christoph Schramm, Michael Trauner. EASL Clinical Practice Guidelines on sclerosing cholangitis. Journal of Hepatology 2022; 77(3): 761 doi: 10.1016/j.jhep.2022.05.011
|
| 39 |
Christos Tsaitas, Anysia Semertzidou, Emmanouil Sinakos. Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World Journal of Hepatology 2014; 6(4): 178-187 doi: 10.4254/wjh.v6.i4.178
|
| 40 |
Josef Finsterer, Sonja Höflich. Successful low-dose azathioprine for myasthenia gravis despite hepatopathy from primary sclerosing cholangitis: a case report. Journal of Medical Case Reports 2010; 4(1) doi: 10.1186/1752-1947-4-356
|
| 41 |
Suhail A. Shaikh, Linda Fitzgerald, Sarah Tischer. Safety and Efficacy of Biologic Agents for the Management of Inflammatory Bowel Disease After Liver Transplantation. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2017; 37(12): 1578 doi: 10.1002/phar.2036
|
| 42 |
Ina Marie Andersen, Guro Tengesdal, Benedicte Alexandra Lie, Kirsten Muri Boberg, Tom Hemming Karlsen, Johannes Roksund Hov. Effects of Coffee Consumption, Smoking, and Hormones on Risk for Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology 2014; 12(6): 1019 doi: 10.1016/j.cgh.2013.09.024
|
| 43 |
John Halliday, Roger W. Chapman. Crohn's Disease and Ulcerative Colitis. 2012; : 579 doi: 10.1007/978-1-4614-0998-4_47
|
| 44 |
Vidas Natasha A., Catherine McAnenny. Advanced Nutrition and Dietetics in Gastroenterology. 2014; : 284 doi: 10.1002/9781118872796.ch4.4
|
| 45 |
Gabriela Handzlik-Orlik, Michał Holecki, Krzysztof Wilczyński, Jan Duława. Osteoporosis in liver disease: pathogenesis and management. Therapeutic Advances in Endocrinology and Metabolism 2016; 7(3): 128 doi: 10.1177/2042018816641351
|
| 46 |
Juliana Silva, Beatriz S. Brito, Isaac Neri de N. Silva, Viviane G. Nóbrega, Maria Carolina S. M. da Silva, Hemerson Dyego de N. Gomes, Flora Maria Fortes, Andrea M. Pimentel, Jaciane Mota, Neogélia Almeida, Valdiana C. Surlo, André Lyra, Raquel Rocha, Genoile O. Santana. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/7604939
|
| 47 |
Li Jiao, Hongying Gan-Schreier, Sabine Tuma-Kellner, Wolfgang Stremmel, Walee Chamulitrat. Sensitization to autoimmune hepatitis in group VIA calcium-independent phospholipase A2-null mice led to duodenal villous atrophy with apoptosis, goblet cell hyperplasia and leaked bile acids. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015; 1852(8): 1646 doi: 10.1016/j.bbadis.2015.04.025
|
| 48 |
Anagha Dafade, Mithilesh Dhamande, Seema Sathe, AnjaliBhoyar Borle, Dipak Shinde, Tanvi Balwani. Comparative evaluation of masseter and buccinator muscle activity using electromyography in denture wearer and nondenture wearer by fabricating dentures with neutral zone technique – An In vivo study. Journal of Datta Meghe Institute of Medical Sciences University 2021; 16(1): 20 doi: 10.4103/1319-4534.322598
|
| 49 |
Dimitrios Bogdanos, Patrick S.C. Leung, M. Eric Gershwin. Mucosal Immunology. 2015; : 1695 doi: 10.1016/B978-0-12-415847-4.00087-2
|
| 50 |
F. Bracci, E. Girolami, G. Torre, F. Panetta, B. Papadatou, D. Knafelz, L. Monti, A. Diamanti. Pediatric Ulcerative Colitis Associated with Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 2013; 19(4): E56 doi: 10.1097/MIB.0b013e318280eb4e
|
| 51 |
D. L. Nepomnyashchikh, V. A. Burkovskaya, S. V. Aidagulova, M. A. Bakarev, O. A. Postnikova, V. I. Kapustina, Zh. V. Nokhrina, E. V. Vinogradova. Structural Modification of the Gastrointestinal Epithelium during Immune-Dependent Granulomatosis. Bulletin of Experimental Biology and Medicine 2011; 150(4): 490 doi: 10.1007/s10517-011-1176-4
|
| 52 |
Shahid A. Khan, Simona Tavolari, Giovanni Brandi. Cholangiocarcinoma: Epidemiology and risk factors. Liver International 2019; 39(S1): 19 doi: 10.1111/liv.14095
|
| 53 |
Martin Kummen, Erik Schrumpf, Kirsten Muri Boberg. Liver abnormalities in bowel diseases. Best Practice & Research Clinical Gastroenterology 2013; 27(4): 531 doi: 10.1016/j.bpg.2013.06.013
|
| 54 |
Giovanni Pompili, Alice Munari, Alessandro Campari, Gianpaolo Cornalba. Imaging of Ulcerative Colitis. 2014; : 59 doi: 10.1007/978-88-470-5409-7_8
|
| 55 |
Ioanna Parisi, James O’Beirne, Roberta E. Rossi, Emmanuel Tsochatzis, Pinelopi Manousou, Eleni Theocharidou, Mark Hamilton, Charles Murray, Owen Epstein, Andrew K. Burroughs. Elevated liver enzymes in inflammatory bowel disease: the role and safety of infliximab. European Journal of Gastroenterology & Hepatology 2016; 28(7): 786 doi: 10.1097/MEG.0000000000000624
|
| 56 |
Mostafa M. Sira, Ahmad M. Sira. B‐cell depletion in autoimmune hepatitis: Is it safe for the bowel?. Hepatology 2016; 64(3): 995 doi: 10.1002/hep.28405
|
| 57 |
Seyed Fazel Nabavi, Maria Daglia, Akbar Hajizadeh Moghaddam, Solomon Habtemariam, Seyed Mohammad Nabavi. Curcumin and Liver Disease: from Chemistry to Medicine. Comprehensive Reviews in Food Science and Food Safety 2014; 13(1): 62 doi: 10.1111/1541-4337.12047
|
| 58 |
|
| 59 |
Igor V. Maev, Igor G. Bakulin, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Inflammatory bowel diseases: Transformation of representations. A review. Terapevticheskii arkhiv 2023; 95(12): 1064 doi: 10.26442/00403660.2023.12.202507
|
| 60 |
Giovanni C Actis, Floriano Rosina, Ian R Mackay. Inflammatory bowel disease: beyond the boundaries of the bowel. Expert Review of Gastroenterology & Hepatology 2011; 5(3): 401 doi: 10.1586/egh.11.23
|
| 61 |
Roger W. Chapman, Kate D. Williamson. Crohn's Disease and Ulcerative Colitis. 2017; : 531 doi: 10.1007/978-3-319-33703-6_52
|
| 62 |
O. Erice, I. Labiano, A. Arbelaiz, A. Santos-Laso, P. Munoz-Garrido, R. Jimenez-Agüero, P. Olaizola, A. Caro-Maldonado, N. Martín-Martín, A. Carracedo, E. Lozano, J.J. Marin, C.J. O'Rourke, J.B. Andersen, J. Llop, V. Gómez-Vallejo, D. Padro, A. Martin, M. Marzioni, L. Adorini, M. Trauner, L. Bujanda, M.J. Perugorria, J.M. Banales. Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1335 doi: 10.1016/j.bbadis.2017.08.016
|
| 63 |
J.-F. Cadranel. Élévation chronique des transaminases : hypertransaminasémie chronique. EMC - Traité de médecine AKOS 2011; 6(1): 1 doi: 10.1016/S1634-6939(11)54649-6
|
| 64 |
Efthymia Alexopoulou, Polis E. Xenophontos, Nikos Economopoulos, Themistoklis N. Spyridopoulos, Olympia Papakonstantinou, Ioanna Panayotou, Konstantina Dimakou, Eleftheria Roma, Nikolaos L. Kelekis. Investigative MR Cholangiopancreatography for Primary Sclerosing Cholangitis–type Lesions in Children With IBD. Journal of Pediatric Gastroenterology and Nutrition 2012; 55(3): 308 doi: 10.1097/MPG.0b013e31825bb3dc
|
| 65 |
|
| 66 |
Brian D. Juran, Elizabeth J. Atkinson, Erik M. Schlicht, Joseph J. Larson, David Ellinghaus, Andre Franke, Konstantinos N. Lazaridis. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis. Liver International 2011; 31(6): 785 doi: 10.1111/j.1478-3231.2010.02420.x
|
| 67 |
C.M. Hall, S. Glaser, G. Alpini. Comprehensive Toxicology. 2018; : 41 doi: 10.1016/B978-0-12-801238-3.95660-5
|
| 68 |
Rodney R. Dietert, Judith T. Zelikoff. Identifying patterns of immune-related disease: use in disease prevention and management. World Journal of Pediatrics 2010; 6(2): 111 doi: 10.1007/s12519-010-0026-1
|
| 69 |
A. Dohan, S.A. Faraoun, M. Barral, Y. Guerrache, M. Boudiaf, X. Dray, C. Hoeffel, M. Allez, O. Farges, L. Beaugerie, T. Aparicio, P. Marteau, E.K. Fishman, O. Lucidarme, C. Eveno, M. Pocard, R. Dautry, P. Soyer. Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features. Diagnostic and Interventional Imaging 2015; 96(9): 871 doi: 10.1016/j.diii.2015.02.009
|
| 70 |
Tianhao Zhou, Vik Meadows, Debjyoti Kundu, Konstantina Kyritsi, Travis Owen, Ludovica Ceci, Guido Carpino, Paolo Onori, Eugenio Gaudio, Nan Wu, Shannon Glaser, Burcin Ekser, Gianfranco Alpini, Lindsey Kennedy, Heather Francis. Mast cells selectively target large cholangiocytes during biliary injury via H2HR‐mediated cAMP/pERK1/2 signaling. Hepatology Communications 2022; 6(10): 2715 doi: 10.1002/hep4.2026
|
| 71 |
Jia-Ping Huai, Jin Ding, Xiao-Hua Ye, Yan-Ping Chen. Inflammatory Bowel Disease and Risk of Cholangiocarcinoma: Evidence from a Meta-analysis of Population-based Studies. Asian Pacific Journal of Cancer Prevention 2014; 15(8): 3477 doi: 10.7314/APJCP.2014.15.8.3477
|
| 72 |
Natalia Pedersen, Dana Duricova, Margarita Elkjaer, Michael Gamborg, Pia Munkholm, Tine Jess. Risk of Extra-Intestinal Cancer in Inflammatory Bowel Disease: Meta-Analysis of Population-Based Cohort Studies. American Journal of Gastroenterology 2010; 105(7): 1480 doi: 10.1038/ajg.2009.760
|
| 73 |
Ingvar Bjarnason, Bu Hayee, Polychronis Pavlidis, Charlotte Kvasnovsky, Astrid Scalori, Guy Sisson, Annika Charlesworth, Hizbullah Shaikh, Einar Bjornsson, Michael A. Heneghan. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis. EBioMedicine 2015; 2(10): 1523 doi: 10.1016/j.ebiom.2015.08.041
|
| 74 |
Daisy Carolina Huertas Martinez, Guilherme Andrade Bulbol, Poliana Corrêa Moreira Braga, Moisés Abtibol Machado. AVALIAÇÃO CLÍNICA DA DOENÇA DE CROHN COM SOBREPOSIÇÃO À HEPATITE AUTOIMUNE: RELATO DE CASO. Revista Contemporânea 2024; 4(1): 4934 doi: 10.56083/RCV4N1-271
|
| 75 |
Emmanouil Sinakos, Keith D. Lindor. Clinical Dilemmas in Inflammatory Bowel Disease. 2011; : 156 doi: 10.1002/9781444342574.ch34
|
| 76 |
Sjoukje‐Marije Haisma, Rinse K. Weersma, Maria E. Joosse, Barbara A. E. de Koning, Tim de Meij, Bart G. P. Koot, Wolters V. M., Obbe Norbruis, Mark J. Daly, Christine Stevens, Ramnik J. Xavier, Jukka Koskela, Manuel A. Rivas, Marijn C. Visschedijk, Henkjan J. Verkade, Ruggero Barbieri, Dianne B. H. Jansen, Eleonora A. M. Festen, Patrick F. van Rheenen, Cleo C. van Diemen. Exome sequencing in patient‐parent trios suggests new candidate genes for early‐onset primary sclerosing cholangitis. Liver International 2021; 41(5): 1044 doi: 10.1111/liv.14831
|
| 77 |
A. A. Yakushev, I. G. Fedorov, L. Yu. Ilchenko, S. S. Shmycova, S. A. Rautbard, S. U. Orlov, I. G. Nikitin, A. V. Salicov. Sepsis like a severe complication of autoimmune liver disease in gastroenterological patients. The Russian Archives of Internal Medicine 2019; 9(2): 145 doi: 10.20514/2226-6704-2019-9-2-145-151
|
| 78 |
|
| 79 |
Hannah Gordon, Johan Burisch, Pierre Ellul, Konstantinos Karmiris, Konstantinos Katsanos, Mariangela Allocca, Giorgos Bamias, Manuel Barreiro-de Acosta, Tasanee Braithwaite, Thomas Greuter, Catherine Harwood, Pascal Juillerat, Triana Lobaton, Ulf Müller-Ladner, Nurulamin Noor, Gianluca Pellino, Edoardo Savarino, Christoph Schramm, Alessandra Soriano, Jürgen Michael Stein, Mathieu Uzzan, Patrick F van Rheenen, Stephan R Vavricka, Maurizio Vecchi, Stephane Zuily, Torsten Kucharzik. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2024; 18(1): 1 doi: 10.1093/ecco-jcc/jjad108
|
| 80 |
Ersilia M. DeFilippis, Sonal Kumar. Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease. Digestive Diseases and Sciences 2015; 60(10): 2873 doi: 10.1007/s10620-015-3699-4
|
| 81 |
Patrick F. van Rheenen. Managing abnormal liver tests in children with inflammatory bowel disease. Current Opinion in Pediatrics 2021; 33(5): 521 doi: 10.1097/MOP.0000000000001045
|
| 82 |
Daniel C Baumgart. What’s new in inflammatory bowel disease in 2008?. World Journal of Gastroenterology 2008; 14(3): 329-330 doi: 10.3748/wjg.14.329
|
| 83 |
Maria Cappello, Claudia Randazzo, Ivana Bravatà, Anna Licata, Sergio Peralta, Antonio Craxì, Piero Luigi Almasio. Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey. Clinical Medicine Insights: Gastroenterology 2014; 7: CGast.S13125 doi: 10.4137/CGast.S13125
|
| 84 |
Jiayun M Fang, Laura Lamps, Amoah Yeboah-Korang, Jerome Cheng, Maria Westerhoff. De Novo Inflammatory Bowel Disease Rarely Occurs During Posttransplant Immunosuppression. American Journal of Clinical Pathology 2021; 156(6): 1113 doi: 10.1093/ajcp/aqab084
|
| 85 |
Sabrina Cardile, Tommaso Alterio, Manila Candusso, Andrea Pietrobattista, Daniela Liccardo, Maria Sole Basso, Bronislava Papadatou, Fiammetta Bracci, Daniela Knafelz, Giuliano Torre. Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectives. Scandinavian Journal of Gastroenterology 2017; 52(6-7): 662 doi: 10.1080/00365521.2017.1298833
|
| 86 |
Mohamed O. Othman, Jeffery Dunkelberg, Praveen K. Roy. Urosdeoxycholic acid in primary sclerosing cholangitis: A meta-analysis and systematic review. Arab Journal of Gastroenterology 2012; 13(3): 103 doi: 10.1016/j.ajg.2012.06.011
|
| 87 |
Rajeev K. Salunke, Murali Dharan, John W. Birk. Inflammatory Bowel Disease. Clinical Gastroenterology 2021; : 265 doi: 10.1007/978-3-030-81780-0_11
|